首页> 外文期刊>Cell Medicine >Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model
【24h】

Long-Term Effects of Fibrin Conduit with Human Mesenchymal Stem Cells and Immunosuppression after Peripheral Nerve Repair in a Xenogenic Model

机译:异种模型中纤维蛋白导管与人间充质干细胞的长期影响以及周围神经修复后的免疫抑制

获取原文
获取外文期刊封面目录资料

摘要

Previously we showed that a fibrin glue conduit with human mesenchymal stem cells (hMSCs) and cyclosporine A (CsA) enhanced early nerve regeneration. In this study long term effects of this conduit are investigated. In a rat model, the sciatic nerve was repaired with fibrin conduit containing fibrin matrix, fibrin conduit containing fibrin matrix with CsA treatment and fibrin conduit containing fibrin matrix with hMSCs and CsA treatment, and also with nerve graft as control. At 12 weeks 34% of motoneurons of the control group regenerated axons through the fibrin conduit. CsA treatment alone or with hMSCs resulted in axon regeneration of 67% and 64% motoneurons respectively. The gastrocnemius muscle weight was reduced in the conduit with fibrin matrix. The treatment with CsA or CsA with hMSCs induced recovery of the muscle weight and size of fast type fibers towards the levels of the nerve graft group. The transplantation of hMSCs for peripheral nerve injury should be optimized to demonstrate their beneficial effects. The CsA may have its own effect on nerve regeneration.
机译:以前,我们表明,具有人间充质干细胞(hMSCs)和环孢素A(CsA)的纤维蛋白胶导管可增强早期神经再生。在这项研究中,研究了这种导管的长期影响。在大鼠模型中,用含血纤蛋白基质的血纤蛋白导管,经CsA处理的含血纤蛋白基质的血纤蛋白导管和经hMSCs和CsA治疗的含血纤蛋白基质的血纤蛋白导管修复,并以神经移植物为对照。在第12周,对照组中34%的运动神经元通过纤维蛋白导管再生轴突。单独或用hMSCs的CsA处理分别导致67%和64%的运动神经元轴突再生。纤维蛋白基质可降低腓肠肌的重量。用hMSCs进行CsA或CsA的治疗可以使肌肉重量和快速型纤维的大小恢复到神经移植组的水平。应优化hMSCs移植以治疗周围神经损伤,以证明其有益作用。 CsA可能对神经再生有其自身作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号